IPPRA / Grant Monitor

2026-07-07
← Board

Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed)

RFA-DA-27-007 · National Institutes of Health

biomedical clinical education workforce economic development public health Health

Closes
2026-10-01 · 86 d
Award ceiling
Award floor
Program funding
$350,000
Expected awards
1
Cost sharing
No
Posted
2026-06-23
Instrument
Cooperative Agreement
Characterization · gpt-5.4-mini · 2026-07-07

This NIH cooperative agreement funds development and delivery of an entrepreneurship and product development research education course for investigators studying drug use, drug misuse, and drug addiction.

Funds
training education
University
direct
social behavioral
minor
engineering
substantial
life biomedical
central
computational data
minor

⚑ Limited competition; eligibility details are in Section III of the NOFO. · Foreign organizations, non-domestic components of U.S. organizations, and foreign components are not allowed. · UE5 Clinical Trial Not Allowed.

Unit fits — one characterization, each unit's own rules

IPPRA 40 partial peripheral portfolio topic: public_health; signature methods: community engaged; social/behavioral work is minor; funds training education, not research (capped); biomedical core — IPPRA health lane is communication/crisis/policy (capped); capped at 40 (non-research funding)
Physical Sciences & Engineering (demo) 40 partial technical depth: substantial; funds training education (capped)
Tom Love Innovation Hub 30 weak prototyping/demonstration stage; deep-tech content

Description

This notice of funding opportunity (NOFO) seeks to establish a course to equip researchers studying drug use, drug misuse, and drug addiction with the skills, knowledge, and practical tools needed to translate their scientific discoveries into impactful real world solutions. The course is envisioned to focus on building capacity in product development, entrepreneurship, and innovation pathways so participants can more effectively move biomedical ideas from early research toward implementation, or commercialization. By combining structured training, mentorship, and hands-on experience, the course is envisioned to accelerate the development of biomedical products that address the complex challenges of drug use, drug misuse, and drug addiction, while fostering an interdisciplinary community of investigators prepared to navigate the scientific, regulatory, and business aspects of this unique research field.

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to applyNon-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Apply

View on Grants.gov → CONTACT: National Institutes of Health <jess.lukacs@nih.gov>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →

Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING